missing translation for 'onlineSavingsMsg'
Learn More

R&D Systems™ Recombinant Human Prostatic Acid Phosphatase/ACPP

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

Marke:  R&D Systems™ 6240-AP-010

399.13 CHF gültig bis 2024-12-16
Benutzen Sie den Promotions-Code "21630" um Ihren Promotions-Preis zu erhalten.


Artikelnummer. 18319487

  • 510.00 CHF / 10 Mikrogramm
Verfügbar ab: 19-12-2024
Sie sich ein, um den Lagerbestand zu sehen
Entdecken Sie weitere Sonderangebote
Zum Warenkorb hinzufügen
Dieser Artikel kann nicht zurückgegeben werden. Rückgaberichtlinie anzeigen

Beschreibung

Beschreibung

Measured by its ability to cleave a substrate, p-Nitrophenyl phosphate (pNPP). The specific activity is >100,000 pmol/min/ug, as measured under the described conditions.
Spezifikation

Spezifikation

P15309
Supplied as a 0.2 μm filtered solution in Tris and NaCl.
M.W. (Observed): 43-55 kDa, reducing conditions; M.W. (theoretical): 41 kDa
10 μg
Do not freeze. 3 months from date of receipt, 2°C to 8°C as supplied. 1 month, 2°C to 8°C under sterile conditions after opening.
ACPP
Recombinant
Prostatic Acid Phosphatase/ACPP
Enzyme Activity
55
Prostatic Acid Phosphatase/ACPP
Mouse myeloma cell line, NS0-derived human Prostatic Acid Phosphatase/ACPP protein Met1-Gln379, with a C-terminal 6-His tag
<1.0 EU / 1 μg of the protein by the LAL method.
Unconjugated
>95%, by SDS-PAGE under reducing conditions and visualized by Colloidal Coomassie™ Blue stain (at 5 μg / lane)
Produktvorschläge

Produktvorschläge

Videos
Sicherheitsdatenblatt (SDS)
Dokumentation

Dokumentation

Zertifikate
Sonderangebote

Sonderangebote